Q2 2023
Released Aug 2, 2023, after the close
10-Q filed Aug 3, 2023, 34 days after period end · 0001653477-23-000047
Q2 2023 · 10-Q
Revenue$481.80M$481.80M +14.7% vs Q2 2022+22.7% vs Q1 2023
Net Income$35.50M$35.50M −40.6% vs Q2 2022−30.0% vs Q1 2023
EPS Diluted$0.97$0.97 −37.0% vs Q2 2022−28.1% vs Q1 2023
Gross Profit$153,000,000+1.6%
Operating Income$120,700,000−0.3%
Operating Cash Flowderived$48,400,000−46.5%
Free Cash Flowderived$26,700,000−56.2%
Margins · derived
Gross margin31.8%−4.1 pt vs Q2 2022
Operating margin25.1%−3.8 pt vs Q2 2022
Net margin7.4%−6.9 pt vs Q2 2022
What the release said
The release
Same quarter
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $481.80M | $419.90M | $358.40M | $270.60M |
| Net Income | $35.50M | $59.80M | $44.30M | $20.20M |
| EPS Diluted | $0.97 | $1.54 | $1.10 | $0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR